Quality of anticoagulation control among patients with atrial fibrillation: An experience of a tertiary care center in Saudi Arabia

Abstract

Quality of anticoagulation in patients with AF receiving medical care in a tertiary care hospital was suboptimal, with nearly 40% of the time spent outside the therapeutic range. Methods to improve anticoagulation control among patients with AF should be implemented.

Rationale and design of individualized quality improvement based on the Computer Analysing system to improve Stroke management quality Evaluation (CASE): a multicenter historically controlled study

“…The primary outcomes are as follows: 7 KPIs including the accomplishment of National Institutes of Health Stroke Scale (NIHSS), intravenous thrombosis within 4.5 h of onset, antiplatelet agent therapy within the first 48 h, statin use after hospitalization and at discharge, antithrombotic therapy at discharge, and anticoagulant treatment for patients with atrial fibrillation at discharge [ 8 , 9 , 11 – 13 ] (see Additional file 2 ).…”

“…1 Flow diagram of the process throughout the trial Fig. 2 The procedure to improve the quality of the medical care in stroke patients 48 h, statin use after hospitalization and at discharge, antithrombotic therapy at discharge, and anticoagulant treatment for patients with atrial fibrillation at discharge [8,9,[11][12][13] (see Additional file 2). The secondary outcomes are as follows: 9 KPIs including prevention of deep vein thrombosis, blood vessel evaluation within 1 week of hospitalization, swallowing function evaluation, blood lipid level assessment, rehabilitation evaluation and implementation, recommendation of life style change, anti-hypertensive therapy, hypoglycemic treatment at discharge, and recurrence rate [10,11,17] (see Additional file 2).…”

“…To enhance the medical care quality by increasing the compliance with evidence-based performance in stroke patients, China Stroke Center Alliance (CSCA) has been launched in China in 2015. CSCA prompted 13 key performance indicators (KPIs) of acute ischemic stroke (AIS) to monitor the routine in-patient medical care quality, based on the AIS guidelines, involving intravenous thrombosis (IVT), antiplatelet therapy, anticoagulant therapy, and so on [8][9][10][11][12][13]. Then afterwards, CSCA annually collected the required data from about 20,000 inpatients among more than 1500 stroke centers [14], and calculated and feedback all of the KPIs to each center.…”

Rationale and design of individualized quality improvement based on the Computer Analysing system to improve Stroke management quality Evaluation (CASE): a multicentre historically controlled study

“…Primary Outcome: 7 KPIs including the accomplish of National Institutes of Health Stroke Scale (NIHSS), intravenous thrombosis within 4.5 hours of onset, antiplatelet agents therapy within the rst 48 hours, statin use after hospitalization and at discharge, antithrombotic therapy at discharge, anticoagulant treatment for patients with atrial brillation at discharge (8,9,(11)(12)(13). (see the additional le 2)…”

Rationale and design of individualized quality improvement based on the Computer Analysing system to improve Stroke management quality Evaluation (CASE): a multicentre historically controlled study

“…To enhance the medical care quality by increasing the compliance with evidence-based performance in stroke patients, China Stroke Center Alliance (CSCA) has been launched in China in 2015. CSCA prompted 13 key performance indicators (KPIs) of acute ischemic stroke (AIS) to monitor the routine in-patient medical care quality, based on the AIS guidelines, involving intravenous thrombosis (IVT), antiplatelet therapy, anticoagulant therapy and so on [8][9][10][11][12][13] . Then afterwards, CSCA annually collected the required data from about 20,000 in-patients among more than 1500 stroke centers 14 , calculated and feedback all of the KPIs to each center.…”